Active surveillance and isolation of asymptomatic carriers of clostridium difficile at hospital admission containing what lies under thewaterline

JAMA Internal Medicine

Volumn 176, Issue 6, 2016, Pages 805-806

  Guh, Alice Y ^a   McDonald, L Clifford ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; CLOSTRIDIUM DIFFICILE INFECTION; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DISEASE SURVEILLANCE; EMERGENCY WARD; HAND WASHING; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INCIDENCE; LONG TERM CARE; NONHUMAN; NOTE; NUCLEIC ACID AMPLIFICATION; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; TERTIARY CARE CENTER; CLOSTRIDIUM INFECTION; CROSS INFECTION; HETEROZYGOTE;

CARRIER STATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HUMANS;

EID: 84973462552     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.1118     Document Type: Note

References (8)

1. Magill SS, Edwards JR, Bamberg W, et al; Emerging Infections Program Healthcare- Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198-1208.
2. Curry SR, Muto CA, Schlackman JL, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013;57(8):1094-1102.
3. Eyre DW, Cule ML, Wilson DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013;369 (13):1195-1205.
4. Longtin Y, Paquet-Bolduc B, Gilca R, et al. Effect of detecting and isolating Clostridium difficile carriers at hospital admission on the incidence of C difficile infections: A quasi-experimental controlled study [published online April 25, 2016]. JAMA Intern Med. doi:10.1001/jamainternmed.2016.0177.
5. Donskey CJ, Sunkesula VC, Jencson AL, et al. Utility of a commercial PCR assay and a clinical prediction rule for detection of toxigenic Clostridium difficile in asymptomatic carriers. J Clin Microbiol. 2014;52(1):315-318.
6. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365(18):1693- 1703.
7. Donskey CJ, Kundrapu S, Deshpande A. Colonization versus carriage of Clostridium difficile. Infect Dis Clin North Am. 2015;29(1):13-28.
8. Abad C, Fearday A, Safdar N. Adverse effects of isolation in hospitalised patients: A systematic review. J Hosp Infect. 2010;76(2):97-102.